| Oct 26 |
Sanofi SA (SNY) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Advances
|
| Oct 25 |
Why Sanofi Stock Flew Higher on Friday
|
| Oct 25 |
Sanofi (SNY) Q3 2024 Earnings Call Transcript
|
| Oct 25 |
Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News
|
| Oct 25 |
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
|
| Oct 25 |
Sanofi Shocks the Market: Massive Q3 Surge, Game-Changing Moves, and Bold Divestment Plans
|
| Oct 25 |
Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales
|
| Oct 25 |
Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments
|
| Oct 25 |
Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat
|
| Oct 25 |
Sanofi earnings boosted by Beyfortus, earlier vaccine sales
|
